Etanercept Completed Phase 2 Trials for Asthma Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00141791Study Evaluating Etanercept in Moderate to Severe Asthma